10-102108130-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001113407.3(LDB1):c.1199G>A(p.Ser400Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113407.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDB1 | ENST00000673968.1 | c.1199G>A | p.Ser400Asn | missense_variant | 11/11 | NM_001113407.3 | ENSP00000501277.1 | |||
LDB1 | ENST00000361198.9 | c.1091G>A | p.Ser364Asn | missense_variant | 11/11 | 1 | ENSP00000354616.5 | |||
LDB1 | ENST00000425280.2 | c.1193G>A | p.Ser398Asn | missense_variant | 11/11 | 5 | ENSP00000392466.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152202Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251438Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135892
GnomAD4 exome AF: 0.000129 AC: 188AN: 1461834Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 98AN XY: 727230
GnomAD4 genome AF: 0.000112 AC: 17AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1199G>A (p.S400N) alteration is located in exon 11 (coding exon 11) of the LDB1 gene. This alteration results from a G to A substitution at nucleotide position 1199, causing the serine (S) at amino acid position 400 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at